Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorOpioid antagonists for alcohol dependenceTargeted opioid receptor antagonists in the treatment of alcohol use disordersNalmefene for the treatment of alcohol use disorders: recent data and clinical potential.Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.Opioid modulators for alcohol dependence.The effects of drinking goal on treatment outcome for alcoholism.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Naloxone blocks ethanol-mediated appetitive conditioning and locomotor activation in adolescent rats.Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatmentA Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder.Naltrexone for the management of alcohol dependence.The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.Development of medications for alcohol use disorders: recent advances and ongoing challenges.IMPROVED TRANSFORMATION OF MORPHOMETRIC MEASUREMENTS FOR A PRIORI PARAMETER ESTIMATION IN A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOLSubjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism.Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.Effects of naltrexone on cortisol levels in heavy drinkers.Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.Acute interaction of baclofen in combination with alcohol in heavy social drinkersUnderstanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers.Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injectionModerators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.Nalmefene for treatment of alcohol dependence.The role of the opioid system in alcohol dependence.The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review.Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder.Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trialsSubjective Response to Alcohol as a Research Domain Criterion.Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.A paradigm for examining stress effects on alcohol-motivated behaviors in participants with alcohol use disorder.Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
P2860
Q22241964-E864B64E-1221-4479-9020-88D7910F2A81Q24235797-3E009723-C1A4-4478-B0A2-20B2CBA22764Q28295125-84E9EE22-E32B-4E0C-9855-54630B75EC90Q31039835-A77FB746-F8E6-4363-A859-1A4960654E0FQ33797971-6725DA40-88B5-4AE5-9908-4FA0DD769972Q33987817-838DBCE5-0E53-485F-90CE-B7C0167AC7ECQ34013720-6E326067-9238-487E-9C98-70C8FE572EFCQ34180425-784BF99C-64FD-496D-A1E5-8C660B3E299FQ34190543-D49A5E57-47CF-4D67-9AC6-8A84847EBB16Q34199824-E4FC2DC5-CABE-4159-96D5-7E897696CFBCQ34277168-638EE2FD-BAE0-4881-BEFC-4818C381C37DQ34288293-A16E170F-4191-49BE-959A-DF27E58D0DD1Q34411076-EB089234-7AD1-4DCB-B353-AC4B99D27621Q34482577-CEE61424-D264-486E-89C9-1A9B27313AF1Q34656944-2ABECB41-E5F0-4CF2-B1D7-DDAAA7799D19Q34689570-95CCDED6-05E3-417F-B5FA-32F509A8B23FQ35622645-5B016C3C-3A20-4C0F-931A-00A072A5E2E4Q36150622-767AD14E-5E6A-42BC-8EC6-B8290FD96387Q36334341-6A8A6849-95EC-48E4-81E4-D4385961A9D6Q36436395-382EC751-F4D1-4CFD-A91F-5B119FAE13F1Q36540015-62E05303-9B38-48C4-BDD2-D1BE02993C0AQ36863387-AC7A573A-0B23-4CFB-B851-D21F15443DDFQ36931792-E0535AFD-0DEB-4AB3-AADB-19A1EAE540FBQ36989434-54A1ED9D-8871-4D80-8194-91754A2CF5F0Q37059531-3CD603BE-BEFC-464B-8A4F-D1EDC8EF7EDEQ37060525-DE7E05C9-337E-414E-BD17-C0B574FD6BD9Q37089324-C5B6D561-CE19-457C-AC32-181B1E43C3E4Q37217415-2AAB39D1-DAB3-4776-A7D5-90C7ED92903AQ37217442-55F65016-6336-44A1-BC9F-FD54AE33EA30Q37344738-30FC5434-B3ED-4FF1-9774-07CBFF7DA729Q37792101-C49B0B36-B4D1-4033-9BA7-9BBEDBC6F94AQ38139197-08D0ED78-F8FD-4054-9B30-C466DC51E83BQ38270731-BADA8A59-23C9-4271-994A-4D18B94A5574Q38464015-B8121D6C-7CF1-47F9-A698-0875090000B3Q38562081-93339F37-227C-4E96-84BD-48B58ED66760Q38603786-074C2E72-C359-4856-A8E2-79772BFB14DBQ38685941-8E14444E-841F-42B1-87CE-D1532E4FA9C9Q38718932-EF18F0A8-A491-42CD-89C8-6855DE18E9A1Q38728818-F9FA3D70-23C9-4363-9130-45D4EBB9AC0CQ38842262-DEF53440-0310-408D-8D7E-0B3006C44CAF
P2860
Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@ast
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@en
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@nl
type
label
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@ast
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@en
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@nl
prefLabel
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@ast
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@en
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@nl
P2093
P2860
P1476
Effects of naltrexone and nalm ...... lcoholics and social drinkers.
@en
P2093
David J Drobes
Konstantin Voronin
Raymond F Anton
Suzanne E Thomas
P2860
P304
P356
10.1097/01.ALC.0000139704.88862.01
P577
2004-09-01T00:00:00Z